Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
16 active Medicare policies list M62.40, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
National · Effective Oct 1, 2026
5 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M62.40 |
|---|---|---|
| Acupuncture and Dry Needling | Apr 5, 2023 | Covered |
| Bathroom and Toilet Equipment and Supplies | Feb 16, 2024 | Covered |
| Electrical Stimulation for Nausea, Vomiting, Motion Sickness and Other Selected Indications | Jan 5, 2024 | Covered |
| Spasticity Management | Jun 21, 2023 | Covered |
| Standing Frames, Tables, and Transfer Boards | Jun 19, 2023 | Covered |
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
J6 · Effective Apr 1, 2026
J9 · Effective Dec 18, 2025